UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies

The lancet respiratory medicine, 2016-07, Vol.4 (7), p.549-556

2016

Volltextzugriff (PDF)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma

Journal of allergy and clinical immunology, 2017-04, Vol.139 (4), p.1167-1175.e2

2017

Volltextzugriff (PDF)

Anti–IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison

Journal of allergy and clinical immunology, 2019-01, Vol.143 (1), p.190-200.e20

2019

Volltextzugriff (PDF)

Evaluation of Potential Continuation Rules for Mepolizumab Treatment of Severe Eosinophilic Asthma

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2018-05, Vol.6 (3), p.874-882.e4

2018

Volltextzugriff (PDF)

Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond)

Future oncology (London, England), 2022-10, Vol.18 (32), p.3651-3665

2022

Volltextzugriff (PDF)

Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study

The Journal of asthma, 2021-04, Vol.58 (4), p.459-470

2021

Volltextzugriff (PDF)

Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study

The Journal of asthma, 2018-02, Vol.55 (2), p.152-160

2018

Volltextzugriff (PDF)

Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison

Respiratory medicine, 2017-02, Vol.123, p.140-148

2017

Volltextzugriff (PDF)

Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2018-05, Vol.6 (3), p.980-986.e1

2018

Volltextzugriff (PDF)

Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations

PharmacoEconomics, 2023-12, Vol.41 (12), p.1589-1601

2023

Volltextzugriff (PDF)

Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom

Breast cancer research : BCR, 2012-11, Vol.14 (6), p.R152-R152

2012

Volltextzugriff (PDF)

Impact of exacerbations on St George's Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational study

The Journal of asthma, 2020-09, Vol.57 (9), p.1006-1016

2020

Volltextzugriff (PDF)

Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma

The clinical respiratory journal, 2022-03, Vol.16 (3), p.252-258

2022

Volltextzugriff (PDF)

Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study

International journal of chronic obstructive pulmonary disease, 2019-05, Vol.14, p.939-951

2019

Volltextzugriff (PDF)

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.595-604

2020

Volltextzugriff (PDF)

Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial

International journal of chronic obstructive pulmonary disease, 2022-01, Vol.17, p.1633-1642

2022

Volltextzugriff (PDF)

Treatment Preferences of Patients with Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups in the United Kingdom, United States, and Germany

Chronic obstructive pulmonary diseases, 2021-01, Vol.8 (1), p.19-30

2021

Volltextzugriff (PDF)

Meta-analysis of Mepolizumab Global Studies Suggest Consistent Therapeutic Response Across a Range of Demographic Sub-groups

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB9-AB9

2017

Volltextzugriff (PDF)

Perception of oral corticosteroid side effects in patients with corticosteroid-dependent asthma

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB96-AB96

2017

Volltextzugriff (PDF)

Abstract 2630: Meta-analysis of pazopanib and trabectedin in 2L+ metastatic synovial sarcoma (2L+ mSS)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2630-2630

2021

Volltextzugriff (PDF)

Reply

Journal of allergy and clinical immunology, 2019-03, Vol.143 (3), p.1267

2019

Volltextzugriff (PDF)

Reply

Journal of allergy and clinical immunology, 2019-03, Vol.143 (3), p.1267-1268

2019

Volltextzugriff (PDF)

WITHDRAWN: Evaluating the Impact of Using a Generic versus a Disease-Specific Quality-of-Life Instrument in Cost-Utility Analyses: A Case Study in Severe Asthma

Value in health, 2018-09

2018

Volltextzugriff (PDF)

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany

International journal of chronic obstructive pulmonary disease, 2020-04, p.595

2020

Volltextzugriff (PDF)

Modelling the overdiagnosis of breast cancer due to mammography screening in womenaged 40 to 49 in the United Kingdom

Breast cancer research : BCR, 2012-11, Vol.14 (6), Article R152

2012

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(13)
Asthma
(11)
Patients
(10)
Respiratory System
(10)
Allergy
(8)
Female
(7)
Asthma - Drug Therapy
(6)
Studies
(6)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(5)
Immunology
(5)
Leukocytes
(5)
Male
(5)
Mepolizumab
(5)
Middle Aged
(5)
Adult
(4)
Aged
(4)
Anti-Asthmatic Agents - Therapeutic Use
(4)
Chronic Obstructive Pulmonary Disease
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma

Anti–IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison

Evaluation of Potential Continuation Rules for Mepolizumab Treatment of Severe Eosinophilic Asthma

Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond)

Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study

Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study

Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison

Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma

Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations

Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom

Impact of exacerbations on St George's Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational study

Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma

Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany

Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial

Treatment Preferences of Patients with Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups in the United Kingdom, United States, and Germany

Meta-analysis of Mepolizumab Global Studies Suggest Consistent Therapeutic Response Across a Range of Demographic Sub-groups

Perception of oral corticosteroid side effects in patients with corticosteroid-dependent asthma

Abstract 2630: Meta-analysis of pazopanib and trabectedin in 2L+ metastatic synovial sarcoma (2L+ mSS)

Reply

Reply

WITHDRAWN: Evaluating the Impact of Using a Generic versus a Disease-Specific Quality-of-Life Instrument in Cost-Utility Analyses: A Case Study in Severe Asthma

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany

Modelling the overdiagnosis of breast cancer due to mammography screening in womenaged 40 to 49 in the United Kingdom

Suchergebnisse filtern